China Cord Blood Corp  

(Public, NYSE:CO)   Watch this stock  
Find more results for CO
2.84
0.00 (0.00%)
May 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 2.21 - 3.20
Open     -
Vol / Avg. 0.00/105,296.00
Mkt cap 196.14M
P/E 10.30
Div/yield     -
EPS 0.28
Shares 69.06M
Beta 0.28
Inst. own 27%
Jun 7, 2013
Q4 2013 China Cord Blood Corp Earnings Release Add to calendar
Mar 18, 2013
China Cord Blood Corp at Roth Conference
Feb 27, 2013
Q3 2013 China Cord Blood Corp Earnings Conference Call and Webcast - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '12) 2012
Net profit margin 21.32% 37.31%
Operating margin 36.62% 35.44%
EBITD margin - 43.15%
Return on average assets 4.68% 8.38%
Return on average equity 8.46% 11.61%
Employees 795 -
Carbon Disclosure Rating - -

Address

48th Floor, Bank of China Tower 1 Garden Road, Central
Hong Kong S.A.R.,
Hong Kong
+85236058180 (Phone)
+85236058181 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

China Cord Blood Corporation provides umbilical cord blood stem cells storage. It is a Hong Kong-based company that provides umbilical cord blood storage services for parents to save cord blood stem cells on behalf of their children. It provides exclusive cord blood storage services in the Beijing Municipality, the Guangdong Province and the Zhejiang Province. Its cord blood storage procedures include Cord Blood Collection, Laboratory Testing, Cord Blood Processing and Stem Cell Storage.

Officers and directors

Yuen Kam Chairman of the Board
Age: 50
Bio & Compensation  - Reuters
Ting Zheng Chief Executive Officer, Director
Age: 40
Bio & Compensation  - Reuters
Albert Chen Chief Financial Officer, Director
Age: 36
Bio & Compensation  - Reuters
Rui Arashiyama Chief Executive Officer - Guangdong and Zhejiang Divisions
Age: 53
Bio & Compensation  - Reuters
Yue Deng Chief Executive Officer - Beijing Division
Age: 42
Bio & Compensation  - Reuters
Xin Xu Chief Technology Officer
Age: 58
Bio & Compensation  - Reuters
Mark D. Chen Non-Executive Independent Director
Age: 44
Bio & Compensation  - Reuters
Ken Lu Non-Executive Independent Director
Age: 48
Bio & Compensation  - Reuters
Jennifer J. Weng Non-Executive Independent Director
Age: 44
Bio & Compensation  - Reuters
Julian Juul Wolhardt Independent Non-executive Director
Age: 39
Bio & Compensation  - Reuters